BlackRock’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $75.1M | Buy |
12,945,785
+306,467
| +2% | +$2.03M | ﹤0.01% | 2278 |
|
|
2025
Q4 | $99.2M | Buy |
12,639,318
+711,619
| +6% | +$5.6M | ﹤0.01% | 2116 |
|
|
2025
Q3 | $97.1M | Buy |
11,927,699
+391,378
| +3% | +$2.6M | ﹤0.01% | 2111 |
|
|
2025
Q2 | $53.9M | Buy |
11,536,321
+741,720
| +7% | +$3.4M | ﹤0.01% | 2405 |
|
|
2025
Q1 | $59.3M | Sell |
10,794,601
-26,527
| -0.2% | -$107K | ﹤0.01% | 2288 |
|
|
2024
Q4 | $36.7M | Buy |
10,821,128
+87,097
| +0.8% | +$280K | ﹤0.01% | 2653 |
|
|
2024
Q3 | $30.6M | Buy |
10,734,031
+401,953
| +4% | +$1.03M | ﹤0.01% | 2777 |
|
|
2024
Q2 | $23.2M | Buy |
10,332,078
+371,572
| +4% | +$749K | ﹤0.01% | 2884 |
|
|
2024
Q1 | $22M | Sell |
9,960,506
-50,885
| -0.5% | -$132K | ﹤0.01% | 2939 |
|
|
2023
Q4 | $23.5M | Buy |
10,011,391
+637,149
| +7% | +$1.18M | ﹤0.01% | 2919 |
|
|
2023
Q3 | $17.4M | Buy |
9,374,242
+39,646
| +0.4% | +$90.8K | ﹤0.01% | 3018 |
|
|
2023
Q2 | $24.5M | Buy |
9,334,596
+921,416
| +11% | +$2.35M | ﹤0.01% | 2907 |
|
|
2023
Q1 | $13.7M | Sell |
8,413,180
-163,033
| -2% | -$204K | ﹤0.01% | 3160 |
|
|
2022
Q4 | $11.4M | Buy |
8,576,213
+347,585
| +4% | +$491K | ﹤0.01% | 3336 |
|
|
2022
Q3 | $12.8M | Buy |
8,228,628
+221,834
| +3% | +$367K | ﹤0.01% | 3287 |
|
|
2022
Q2 | $12.3M | Buy |
8,006,794
+6,011,915
| +301% | +$12.7M | ﹤0.01% | 3398 |
|
|
2022
Q1 | $5.11M | Buy |
1,994,879
+199,366
| +11% | +$487K | ﹤0.01% | 3949 |
|
|
2021
Q4 | $5.26M | Buy |
1,795,513
+269,705
| +18% | +$583K | ﹤0.01% | 3978 |
|
|
2021
Q3 | $3.74M | Sell |
1,525,808
-158,358
| -9% | -$460K | ﹤0.01% | 4053 |
|
|
2021
Q2 | $6.86M | Sell |
1,684,166
-2,080,782
| -55% | -$7.94M | ﹤0.01% | 3784 |
|
|
2021
Q1 | $17M | Buy |
3,764,948
+117,730
| +3% | +$635K | ﹤0.01% | 3271 |
|
|
2020
Q4 | $17.9M | Buy |
3,647,218
+104,388
| +3% | +$522K | ﹤0.01% | 3063 |
|
|
2020
Q3 | $21M | Buy |
3,542,830
+727,982
| +26% | +$2.91M | ﹤0.01% | 2834 |
|
|
2020
Q2 | $7.49M | Buy |
2,814,848
+478,430
| +20% | +$1.67M | ﹤0.01% | 3354 |
|
|
2020
Q1 | $4.55M | Buy |
2,336,418
+139,671
| +6% | +$601K | ﹤0.01% | 3396 |
|
|
2019
Q4 | $15.5M | Buy |
2,196,747
+65,498
| +3% | +$541K | ﹤0.01% | 3022 |
|
|
2019
Q3 | $20.9M | Sell |
2,131,249
-7,532
| -0.4% | -$84.6K | ﹤0.01% | 2791 |
|
|
2019
Q2 | $24.5M | Buy |
2,138,781
+348,308
| +19% | +$3.66M | ﹤0.01% | 2738 |
|
|
2019
Q1 | $18M | Buy |
1,790,473
+1,145,438
| +178% | +$14.7M | ﹤0.01% | 2800 |
|
|
2018
Q4 | $11M | Buy |
645,035
+250,619
| +64% | +$5.03M | ﹤0.01% | 3038 |
|
|
2018
Q3 | $6.93M | Buy |
394,416
+369,416
| +1,478% | +$8.02M | ﹤0.01% | 3396 |
|
|
2018
Q2 | $475K | Buy |
+25,000
| New | +$486K | ﹤0.01% | 4115 |
|
Other funds holding XERS
VCM
RA
N
VPM
